# Elicio Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 4, 2025

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-04
- Accepted by EDGAR: Jun 4, 2025, 17:06 ET
- Period: not reported
- Accession: 0000950170-25-081739
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000095017025081739/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000095017025081739/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000095017025081739/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 4, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-081739. Last ingested by Listed: Nov 14, 2026, 18:50 ET. No prices; not investment advice.
